Vortioxetine treatment elevates serum BDNF levels in MDD patients along with the improvement of cognitive and emotional characteristics

dc.contributor.authorTroian, O. S.
dc.contributor.authorLevada, O. A.
dc.contributor.authorТроян, Олександра Сергіївна
dc.contributor.authorЛевада, Олег Анатолійович
dc.date.accessioned2025-04-04T07:09:56Z
dc.date.available2025-04-04T07:09:56Z
dc.date.issued2020
dc.identifier.citationTroian O. Vortioxetine treatment elevates serum BDNF levels in MDD patients along with the improvement of cognitive and emotional characteristics / O. Troian, O. Levada // European Neuropsychopharmacology. - 2020. - Vol. 40, Suppl. 1. - P. S422- S423.uk_UK
dc.identifier.urihttps://zsmu.rosbai.com/handle/123456789/22322
dc.language.isoenuk_UK
dc.subjectтези доповідейuk_UK
dc.titleVortioxetine treatment elevates serum BDNF levels in MDD patients along with the improvement of cognitive and emotional characteristicsuk_UK
dc.typeOtheruk_UK

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
troian2020.pdf
Size:
71.87 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.13 KB
Format:
Plain Text
Description: